John Mandrola is a Cardiology physician affiliated with Baptist Health Louisville. OpenAlex indexes 115 publications with 5,615 citations (h-index 24); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3900 Kresge Way
Suite 60
Louisville, KY 40207
Telephone
502-893-7710Provider last certified this registry record 11 Dec 2020.
Clinical trials
- NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
Sponsor: Biosense Webster, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20251 payment
- Boston Scientific CorporationProgram year20251 payment
- Boston Scientific CorporationProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
57.8%Beta blocker28.9%Carvedilol26%Metoprolol Tartrate26%Metoprolol Succinate25%Atenolol14%Sotalol7%Nadolol3%Part D<11 patientsAntiarrhythmic10.1%Dofetilide47%Amiodarone Hcl25%Flecainide Acetate17%Propafenone Hcl11%Part D<11 patients+ 10 more classes in this area
Blood & clotting
40.4%Factor Xa inhibitor27.5%Eliquis62%Xarelto38%Part D≥120 patientsVitamin K antagonist12%Warfarin Sodium91%Jantoven9%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
1.8%Potassium supplement1.4%Potassium Chloride100%Part D<11 patientsSGLT2 inhibitor0.4%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Bayesian Analytical Methods in Cardiovascular Clinical Trials: Why, When, and How
Canadian Journal of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Sreedevi Gondi, MD
Baptist Health Louisville
Aurora Cruz, MD
Baptist Health Louisville
Mariano Camporrotondo, MD
Baptist Health Louisville
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”